Skip to main content
Clinical Trials/NCT04383665
NCT04383665
Completed
Not Applicable

Evaluation of Neurocognitive Changes in Parkinson's Disease Patients Following Acute Low Frequency Deep Brain Stimulation

University of Southern California1 site in 1 country12 target enrollmentJanuary 31, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
University of Southern California
Enrollment
12
Locations
1
Primary Endpoint
Delis-Kaplan Executive Function System Verbal Fluency
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Rationale: Parkinson's disease patients with deep brain stimulation electrodes represent a unique opportunity to study the influence of basal ganglia on neurocognitive function.

Intervention: Patients' deep brain stimulators will be turned off or on and the frequency will be changed to either theta or gamma.

Objectives: To identify differences in higher cognitive functions with stimulation "on" and "off" and theta versus gamma frequency stimulation.

Study population: 12 patients who had previously undergone bilateral STN deep brain stimulation implantation.

Study methodology: Patients will undergo four sessions of neuropsychological testing (RNGT, verbal fluency, D-KEFS CWIT) at baseline, no stimulation, theta stimulation and gamma stimulation, in random order over one day.

Study outcomes: Test results of RNGT, verbal fluency, D-KEFS CWIT. Follow-up: none

Statistics: Test results will be analyzed using within-subjects statistical tests.

Registry
clinicaltrials.gov
Start Date
January 31, 2020
End Date
March 3, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Darrin J Lee, MD, PhD

Assistant Professor of Neurosurgery

University of Southern California

Eligibility Criteria

Inclusion Criteria

  • Male or female patients who had previously undergone bilateral STN deep brain stimulation implantation
  • Age \>18 years old
  • Stable medication regimen for at least 3 months.
  • Patient informed and able to give written consent
  • Able to comply with all testing, follow-ups and study appointments and protocols

Exclusion Criteria

  • History of epilepsy or seizure
  • History of major substance abuse
  • Patients with baseline settings at less than 1.5 V will be excluded from the study

Outcomes

Primary Outcomes

Delis-Kaplan Executive Function System Verbal Fluency

Time Frame: 5-15 minutes following stimulation frequency setting change.

Number of words per category in one minute

Delis-Kaplan Executive Function System Color Word Interference Task

Time Frame: 5-15 minutes following stimulation frequency setting change.

Time to completion of a color-word interference task

Random Number Generation

Time Frame: 5-15 minutes following stimulation frequency setting change.

Listing of 100 numbers at 1 Hz in a random order. Evan's RNG: a measure of disproportion with which one number follows another in a sequence. Scores range from 0 (equal proportion of sequence pairs) to 1 (maximum disproportion of sequence pairs). A higher score indicates a lower randomness and poorer exective function. Count score 1: a measure of propensity to count in steps of 1. The length of each sequence with steps of 1 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 1) to 100000 (all sequences with steps of 1). A higher score indicates lower randomness and poorer exective function. Count score 2: a measure of propensity to count in steps of 2. The length of each sequence with steps of 2 is squared. The total of these is summed. Scores range from 0 (no sequences with steps of 2) to 100000 (all sequences with steps of 2). A higher score indicates lower randomness and poorer exective function. Evan's RNG, count score 1 and cou

Study Sites (1)

Loading locations...

Similar Trials